The Effectiveness of the Serum IgA Level in Diagnosing IgA Nephropathy.
- Author:
Myeong Sung KIM
1
;
Gyu Tae SHIN
;
Hyun Ee YIM
;
Seung Jung KIM
;
Seung Soo SHEEN
;
Kyoung Ai MA
;
Nam Han CHO
;
Young Il CHOI
;
Heung Soo KIM
;
Do Hun KIM
Author Information
1. Department of Nephrology, Ajou University School of Medicine, Suwon, Korea. gtshin@madang.ajou.ac.kr
- Publication Type:Original Article
- Keywords:
Serum immunoglobulin A;
Immunoglobulin A nephropathy
- MeSH:
Complement System Proteins;
Diagnosis;
Fluorescent Antibody Technique;
Glomerulonephritis;
Glomerulonephritis, IGA*;
Humans;
Immunoglobulin A*;
Odds Ratio;
Risk Factors
- From:Korean Journal of Nephrology
2002;21(1):152-157
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Immunoglogulin A(IgA) nephropathy is the most common primary glomerular disease throughout the world. 30-50% of patients with IgA nephropathy(IgAN) have high serum IgA concentrations. However, we do not know if the degree of elevation in IgA level increases the likelihood of having IgAN. Neither do we know if the IgA level has any association with pathological findings of IgAN. METHODS: We analyzed the relationships between IgAN and the levels of serum IgA which has been a routine part of the study in all patients with glomerulonephritis in our institution for the last 4 years. We reviewed 270 patients in whom the pathological diagnosis and the results of their IgA levels were both available. RESULTS: Of 80 patients who were IgA nephropathy, 26 patients(32.5%) had higher than normal cut- off value of serum IgA(385 mg/dL). In contrast, 8.9 % of patients with other types of glomerulonephropathies showed the values above normal(p<0.0001). The risk ratio for an increase of one unit of the IgA level was 1.0025(logistic regression, p=0.0043), which was increased to 1.0079 when patients with low complement levels were excluded from the analysis. The data were also analyzed according to the immunofluorescence microscopic findings of IgAN, which were found to have no significant correlation with IgA concentrations. CONCLUSION: The IgA level is a risk factor for IgAN throughout the whole range. However, it does not correlate with the IgA deposition in the renal tissue. We believe that this study will help understanding the interpretation of IgA levels in patients with IgAN.
